Texas suit against J&J over drug to go to trial
AUSTIN, Texas (AP) — Texas is seeking more than $1 billion in damages in a lawsuit that accuses Johnson & Johnson of overstating the safety of an anti-psychotic drug and influencing its use in the state's Medicaid program.
Texas suit against J&J over drug goes to trial
A clash between Texas and Johnson & Johnson that could end up costing the drug maker $1 billion opened Tuesday with prosecutors accusing the company of plundering the state Medicaid program by overstating the safety of an expensive anti-psychotic drug and improperly influencing officials and doctors to push the medication.
J&J to Pay $158 Million to Settle Texas Risperdal Drug Case
Johnson & Johnson agreed to pay $158 million to settle Texas officials’ claims that the drugmaker fraudulently marketed its Risperdal anti-psychotic drug, ending a trial over the allegations.
J&J to Pay $158M to Settle Texas Drug Case
Johnson & Johnson (JNJ) agreed to pay $158 million to settle Texas officials’ claims that the drugmaker fraudulently marketed its Risperdal anti-psychotic drug, ending a trial over the allegations.
Deutsche Bank, News Corp., Samsung, Terra Firma, Barclays in Court News
Ma Sin-chi, a Deutsche Bank AG (DBK) managing director in Hong Kong , was charged with accepting HK$24.8 million ($3.2 million) in bribes in exchange for advice on the trading of derivative warrants issued by the bank.
SC judge upholds $327M verdict for J&J marketing
TRENTON, N.J.—A South Carolina judge has upheld a $327 million civil penalty against health giant Johnson & Johnson, which in March was found guilty by a jury of overstating the safety and effectiveness of its former blockbuster antipsychotic drug, Risperdal.
Ennis & Ennis, P.A. Questions Why the FDA Allowed Five Members to Sit on Yaz Birth Control Advisory Panel Despite ...
Ennis & Ennis, P.A. questions the ties that various FDA Yaz Birth Control Advisory Panelists had with Bayer. Ennis & Ennis, P.A. is a national plaintiff's personal injury law firm that concentrates its practice in mass torts representing individuals against pharmaceutical companies and medical devices makers.(PRWEB) January 17, 2012 In December 2011, a U.S. Food and Drug Administration (FDA ...
J&J Pushed Risperdal for Kids Without Approval, Memo Shows
A Johnson & Johnson (JNJ) unit marketed its Risperdal drug in 2004 to doctors working with troubled children even though regulators hadn’t approved the drug for those patients, company records show.
Key Opinion Leaders Who Lend Their Names to Ghostwritten Medical Articles Should Be Held Legally Liable, Article States
Prominent physicians who lend their names to ghostwritten, industry-financed medical articles that convey fraudulent misinformation resulting in harm to patients should be held legally liable, according to a new article published today in PLoS. The article was co-written by Baum, Hedlund, Aristei & Goldman attorney Bijan Esfandiari along with Dr. Xavier Bosch from the University of Barcelona and ...